JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online September 16, 2009, 10.2967/jnumed.109.064345
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jnumed.109.064345v1
50/10/1666    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by MacDonald, L.
Right arrow Articles by Kinahan, P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by MacDonald, L.
Right arrow Articles by Kinahan, P.
Journal of Nuclear Medicine Vol. 50 No. 10 1666-1675
© 2009 by Society of Nuclear Medicine

doi: 10.2967/jnumed.109.064345

Basic Science Investigation

Clinical Imaging Characteristics of the Positron Emission Mammography Camera: PEM Flex Solo II

Lawrence MacDonald1, John Edwards1,2, Thomas Lewellen1, David Haseley2, James Rogers2 and Paul Kinahan1

1 Radiology Department, University of Washington, Seattle, Washington; and 2 Swedish Cancer Institute, Seattle, Washington

Correspondence: For correspondence or reprints contact: Lawrence MacDonald, Radiology Department, University of Washington, 1959 NE Pacific Ave., Old Fisheries Center, Room 222, Box 357987, Seattle, WA 98195. E-mail: macdon{at}u.washington.edu

We evaluated a commercial positron emission mammography (PEM) camera, the PEM Flex Solo II. This system comprises two 6 x 16.4 cm detectors that scan together covering up to a 24 x 16.4 cm field of view (FOV). There are no specific standards for testing this detector configuration. We performed several tests important to breast imaging, and we propose tests that should be included in standardized testing of PEM systems. Methods: We measured spatial resolution, uniformity, counting- rate linearity, recovery coefficients, and quantification accuracy using the system's software. Image linearity and coefficient of variation at the edge of the FOV were also characterized. Anecdotal examples of clinical patient data are presented. Results: The spatial resolution was 2.4 mm in full width at half maximum for image planes parallel to the detector faces. The background variability was approximately 5%, and quantification accuracy and recovery coefficients varied within the FOV. Positioning linearity began at approximately 13 mm from the edge of the detector housing. The coefficient of variation was significantly higher close to the edge of the FOV because of limited sensitivity in these image planes. Conclusion: A reconstructed spatial resolution of 2.4 mm represented a significant improvement over conventional whole-body PET scanners and should reduce the lower threshold on lesion size and tracer uptake for detection in the breast. Limited-angle tomography and a lack of data corrections result in spatially variable quantitative results. PEM acquisition geometry limits sampling statistics at the chest-wall edge of the camera, resulting in high variance in that portion of the image. Example patient images demonstrate that lesions can be detected at the chest-wall edge despite variance artifacts, and fine structure is visualized routinely throughout the FOV in the focal plane. The PEM Flex camera should enable the functional imaging of breast cancer earlier in the disease process than whole-body PET.

Key Words: positron emission mammography (PEM) • dedicated breast PET • breast cancer imaging

COPYRIGHT © 2009 by the Society of Nuclear Medicine, Inc.


Related articles in JNM:

This Month in JNM

JNM 2009 50: 11A-12A. [Full Text]  






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2009 by the Society of Nuclear Medicine.